IP Library › Granted Patent US 8,709,777
Granted Patent B2
US 8,709,777 · App. 12/995,706 · Granted Apr 29, 2014

Variants of a family 44 xyloglucanase

Inventors: Werner Besenmatter (Soeborg, DK); Esben Peter Friis (Herlev, DK); Keith Gibson (Bagsvaerd, DK); Frank Winther Rasmussen (Roskilde, DK); Michael Skjoet (Jyllinge, DK)
Assignee: Novozymes A/S
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,709,777
App. No.
12/995,706
Granted
Apr 29, 2014
Kind
B2
Abstract

The present invention relates to variants of a parent xyloglucanase. The present invention also relates to polynucleotides encoding the variant xyloglucanases and to nucleic acid constructs, vectors, and host cells comprising the polynucleotide.

Claims (60)

1. A non-naturally occurring variant of a parent xyloglucanase, which comprises a substitution at a position corresponding to position 68 of SEQ ID NO: 3 with H, L, M, or N, wherein

(a) the variant has at least 95% identity to the amino acid sequence of SEQ ID NO: 3;

(b) the parent xyloglucanase is a family 44 xyloglucanase; and

(c) the variant has xyloglucanase activity.

2. The variant of claim 1 , wherein the variant has two alterations.

3. The variant of claim 1 , which comprises one or more of the following combinations of alterations:

K13A+Q68H+T92V+K118A+Q137E+R156Y+G200P;

D33V+Q68H+N168H+V4501;

Q68H+S76W+T92V+K118A+Q137E+R156Y+G200P+N331F;

Q68H+T92A,D,I,S,V,Y+K118A+K129A+R156Y+G200P+N331F;

Q68H+T92N+D97N+K118A+K129A+R156Y+G200P+N331F;

Q68H+T92S+K118A+K129A+R156Y+G200P+G274D+N331F;

Q68H+T92V+K118A+S123P,T+K129A+Q137E+R156Y+G200P+N331F;

Q68H+T92V+K118A+K129A+Q137E+R156Y+H193T;

Q68H+T92V+K118A+K129A+Q137E+R156Y+H193T+G200P+M310V+E446K;

Q68H+T92V+K118A+K129A+Q137E+R156Y+H193T+N331H, K, Q;

Q68H+T92V+K118A+K129A+Q137E+R156Y+H193T+D366H;

Q68H+T92V+K118A+K129A+Q137E+R156Y+G200P+A224P+N331F;

Q68H+T92V+K118A+K129A+Q137E+R156Y+G200P+N331F;

Q68H+T92V+K118A+K129A+R156Y+H193T;

Q68H+T92V+K118A+K129A+R156Y+H193T+G200P+M310V;

Q68H+T92V+K118A+K129A+R156Y+H193T+D366H;

Q68H+T92V+K118A+K129A+R156Y+G200P+N331F;

Q68H+T92V+K118A+Q137E+N140F+R156Y+G200P+K470T;

Q68H+T92V+K118A+Q137E+R156Y+G200P+M311F;

Q68H+T92V+K118A+Q137E+R156Y+G200P+D324N;

Q68H+T92V+K118A+Q137E+R156Y+G200P+N331F;

Q68H+T92V+K118A+Q137E+R156Y+G200P+K470T;

Q68H+T92V+K118A,R+R156Y,F;

Q68H+T92V+K118R+R156Y+H193T+D366H;

Q68H+T92V+Q137E+R156Y+G200P+N331F;

Q68H+T92V+R156F+G200P+M310V+S484C;

Q68H+T92V+R156F,V,Y+G200P+M311F;

Q68H+T92V+R156F,V,Y+G200P+M310V+N331F;

Q68H+T92V+R156F,Y+H193T;

Q68H+T92V+R156F,Y+H193T+G200P+M310V;

Q68H+T92V+R156F,Y+H193T+D366H;

Q68H+T92V+R156Y;

Q68H+T92V+G200P+M310V;

Q68H+T92V+G200P+M310V+N331F;

Q68H+K118A+K129A+R156Y+G200P+N331F;

Q68H+K118A+R156V+G200P+N331F;

Q68H+K118A+R156Y+H193T+D366H;

Q68H+K118R+R156F,Y;

Q68H+K118R+R156Y+G200P;

Q68H+K118S+R156F+G200P+G274D+N331F;

Q68H+K129A,T+R156K+G200P+N331F;

Q68H+R156F,V,Y+G200P+N331F;

Q68H+R156Y;

Q68H+R156Y+H193T;

Q68H+R156Y+H193T+G200P+M310V;

Q68H+R156Y+H193T+D366H; or

Q68H+G200P+N331F.

4. The variant of claim 1 , which further comprises one or more substitutions at one or more additional positions selected from the group consisting of 123, 156, 118, 200, 129, 137, 193, 92, 83, 149, 34, 340, 332, 9, 76, 331, 310, 324, 498, 395 and 366.

5. The variant of claim 4 , wherein the variant comprises one or more substitutions selected from the group consisting of: S123P,T; R156Y,F,V,I,K,W,L,M; K118A,R; G200P,E,S,D; K129T,A,S; Q137E; H193T,S,D; T92V,I,A,S; A83E; Q149E; L34F,I,V; R340T,N; S332P; T9D; S76W,V,I,K,R,T; N331F,C; M310I,V,L; D324N; G498A,D; D395G and D366H.

6. The variant of claim 5 , wherein the variant comprises one or more substitutions selected from the group consisting of: S123P; R156Y,F; K118A; G200P,E; K129T,A; Q137E; H193T; T92V and N331F.

7. The variant of claim 1 , wherein the variant has improved chemical stability compared to the parent xyloglucanase.

8. The variant of claim 7 , wherein the improved chemical stability results in improved detergent stability.

9. A formulation comprising the variant of claim 1 .

10. The formulation of claim 9 , wherein the formulation is a liquid formulation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2010
From: BESENMATTER, WERNER; FRIIS, ESBEN PETER; GIBSON, KEITH; RASMUSSEN, FRANK WINTHER; SKJOET, MICHAEL
To: NOVOZYMES A/S
Reel/Frame 025521/0213 →
Priority Claims (1)
EP 08157769 · Jun 6, 2008 · regional
Continuity (2)
Provisional Application 61059832 · Jun 9, 2008
Related Publication 20110092409A1 · Apr 21, 2011